[ad_1] A building on the campus at the world headquarters of Illumina is shown in San Diego, California, September 1, 2021. Mike Blake | Reuters The Securities and Exchange Commission is investigating Illumina over its controversial $7.1 billion acquisition of cancer test developer Grail, the DNA sequencing company said in a securities filing late Thursday. …
[ad_1] Last Updated: July 08, 2023, 02:22 IST United States of America (USA) Musk wants to recoup excess fees that Wachtell charged under an agreement signed on the day of closing by one of its partners and Twitter’s chief legal officer Vijaya Gadde. Elon Musk sues law firm Wachtell, Lipton, Rosen & Katz over a…
[ad_1] Rafael Henrique | Lightrocket | Getty Images Activist investor Carl Icahn on Thursday won enough support from Illumina shareholders to oust the biotech company’s board chair. Shareholders booted Chairman John Thompson. An Illumina spokesperson said a new chair will be chosen in the next few weeks. Icahn had urged shareholders to vote off the…
[ad_1] Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn on Friday called Illumina’s first-quarter results “very disappointing” and slammed the DNA sequencing company’s new plans to cut costs. The activist investor, who owns a 1.4% stake in Illumina, is in a heated proxy…
[ad_1] A building on the campus at the world headquarters of Illumina is shown in San Diego, California, September 1, 2021. Mike Blake | Reuters Illumina on Tuesday unveiled plans to cut costs in a bid to improve the DNA sequencing company’s shrinking margins. The plans aim to reduce Illumina’s annualized run rate expenses by…
